Form 4: Clarus Corp Director Ottmann Acquires Stock Options
Statement of Changes in Beneficial Ownership
Clarus Corporation Director Susan Ottmann was granted stock options to purchase 20,000 shares of common stock.
Summary
- Susan Ottmann, a Director at Clarus Corporation, has been granted stock options.
- The options are for 20,000 shares of the company's common stock.
- The exercise price for these options is $3.11 per share.
- The grant date was May 28, 2026, with an expiration date of May 28, 2036.
- These options were granted under the Issuer's Amended and Restated 2015 Stock Incentive Plan.
- Vesting of the options will occur in tranches: 5,000 shares on June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard insider grant of stock options rather than a significant financial event or strategic shift.
Positives
- Director acquisition of stock options can signal confidence in the company's future performance.
- The stock incentive plan is designed to align management and director interests with shareholders.
- The options are exercisable over a ten-year period, providing long-term incentive.
Negatives
- The filing does not provide details on the rationale behind the option grant.
- The exercise price of $3.11 per share implies the stock price needs to appreciate significantly for the options to be profitable.
Risks
- The value of the stock options is directly tied to the future stock price performance of Clarus Corporation.
- If the company's stock price does not exceed the exercise price of $3.11, the options may expire worthless.
- Vesting schedules introduce a risk that the director may not remain with the company for the full vesting period.
Future Outlook
The future outlook for the stock options is contingent on the company's stock performance, with vesting scheduled through March 2027 and expiration in May 2036.
Industry Context
StockSavvy.ai notes that the granting of stock options to directors is a common practice in the technology and manufacturing sectors, aiming to incentivize long-term value creation and align executive interests with shareholders.
Stakeholder Impact
- Shareholders: The grant of options does not immediately dilute share count but could lead to dilution if exercised. It also aligns director incentives with stock price appreciation.
- Employees: The existence of a stock incentive plan may positively influence employee morale and retention.
- Management: Directors are incentivized to perform and increase shareholder value.
Next Steps
- Monitor the vesting of the stock options.
- Track the company's stock performance relative to the option exercise price.
Key Dates
| Date | Description |
|---|---|
| 05/28/2026 | Earliest transaction date / Grant date of stock options. |
| 06/30/2026 | First vesting date for a tranche of stock options. |
| 09/30/2026 | Second vesting date for a tranche of stock options. |
| 12/31/2026 | Third vesting date for a tranche of stock options. |
| 03/31/2027 | Fourth vesting date for a tranche of stock options. |
| 05/28/2036 | Expiration date of the granted stock options. |
| 06/01/2026 | Date of report signature. |
Keywords
Clarus Corporation, CLAR, Form 4, Stock Options, Director, Beneficial Ownership, Securities Exchange Act, Stock Incentive Plan, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.